Export 4 results:
Author Title Type [ Year(Desc)]
Filters: Author is Saxon, Andrew  [Clear All Filters]
2013
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., “Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.”, Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.
2016
Y. - I. Hser, Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K. M., Woody, G., Liu, D., Wakim, P., Matthews, A. G., Hatch-Maillette, M., Jelstrom, E., Wiest, K., McLaughlin, P., and Ling, W., “Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.”, Addiction, vol. 111, no. 4, pp. 695-705, 2016.
2017
K. - C. Chang, Der Wang, J. -, Saxon, A., Matthews, A. G., Woody, G., and Hser, Y. - I., “Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.”, Int J Drug Policy, vol. 43, pp. 1-6, 2017.
2020
G. B. Bart, Saxon, A., Fiellin, D. A., McNeely, J., Muench, J. P., Shanahan, C. W., Huntley, K., and Gore-Langton, R. E., “Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.”, Addict Sci Clin Pract, vol. 15, no. 1, p. 4, 2020.